Table 1.
Variables | A/A (n = 66) | A/G+G/G (n = 36) | P Valuea |
---|---|---|---|
Gender | 0.34 | ||
Male | 43 (65.15) | 20 (55.56) | |
Female | 23 (34.85) | 16 (44.44) | |
Age (year) | 53.15 ± 10.94 | 54 ± 10.97 | 0.85 |
ABO Compatibility | 0.84 | ||
Compatible | 56 (84.85) | 30 (83.33) | |
Incompatible | 10 (15.15) | 6 (16.67) | |
Original disease | 0.69 | ||
HCV | 22 (33.33) | 15 (41.67) | |
HBV | 13 (19.70) | 8 (22.22) | |
Autoimmune disease | 7 (10.61) | 4 (11.11) | |
Others | 24 (36.36) | 9 (25) | |
MELD | 19.24 ± 8.83 | 16.25 ± 7.66 | 0.07 |
Child‐Turcotte‐Pugh | 0.80 | ||
A | 5 (7.58) | 3 (8.33) | |
B | 20 (30.30) | 13 (36.11) | |
C | 41 (62.12) | 20 (55.56) | |
Donor | 0.42 | ||
Parent | 6 (9.09) | 0 (0) | |
Child | 36 (54.55) | 23 (63.89) | |
Sibling | 9 (13.64) | 5 (13.89) | |
Spouse | 14 (21.21) | 7 (19.44) | |
Others | 1 (1.52) | 1 (2.78) | |
HLA total mismatches | 3.42 ± 1.60 | 3.66 ± 1.51 | 0.53 |
HLA Class I mismatch | 2.31 ± 1.15 | 2.47 ± 1.10 | 0.51 |
HLA Class II mismatch | 1.10 ± 0.69 | 1.19 ± 0.66 | 0.56 |
GRWR | 0.90 ± 0.18 | 0.89 ± 0.24 | 0.97 |
GRWR, graft‐to‐recipient weight ratio; HBV, hepatitis B virus; HCV, hepatitis C virus; LDLT, Living donor liver transplantation; MELD, model for end‐stage liver disease; SD, standard deviation
Categorical variables are presented as number(%) while continuous variables are presented as mean±SD
Pearson's chi‐squared test/Wilcoxon rank sum tests, A difference was considered significant if P‐value was < 0.05.
Typed HLA antigens: HLA‐A1, HLA‐A2, HLA‐B1, HLA‐B2, HLA‐DR1, and HLA‐DR2.